Leah Carreño, Eliot Thomasma, John Mason, Will Pitt, Michael Crowell
7 min
Traditional sports rehabilitation often relies on step-wise, time-based protocols that fail to account for the complex, individual needs of athletes. This paper introduces the Specific and Purposeful Evaluation, Assessment, and Rehabilitation (SPEAR) paradigm. This model shifts the focus from rigid timelines to a collaborative, impairment-based approach that evolves alongside the athlete's biological healing and functional progress. By integrating clinical reasoning into every session, rehabilitation professionals can better tailor interventions to the athlete's specific sport, position, and psychological state.
The authors outline four parallel focus areas that must be managed throughout the rehabilitation continuum:
Many athletes return to sport without regaining their pre-injury functional or competitive levels, and previous injury remains the strongest predictor of future injury. By moving away from "one-size-fits-all" protocols and toward a model that prioritizes objective functional benchmarks, psychological readiness, and the integration of rehabilitation with sport-specific strength and conditioning, clinicians can improve the quality of care. This comprehensive approach ensures that athletes are not just "cleared" to play, but are physically and mentally prepared to perform at or above their pre-injury levels, thereby reducing the risk of reinjury.
Sam: So how do you know when you're pushing too hard?
Alex: That's where optimal loading comes in, and the mechanism matters here. The concept rests on mechanotransduction — the process by which cells convert mechanical stress into biochemical signals that drive structural adaptation. Tendons, cartilage, and muscle all require a specific dose of mechanical input to remodel. Too little load and you get disuse atrophy and delayed healing. Too much and you accumulate tissue damage faster than repair can keep up. The target is the window in between, and that window shifts as the tissue adapts.
Sam: And the window is different for every athlete and every stage of recovery — which is exactly why a fixed timeline can't capture it.
Alex: That's the argument. The paper frames this as a dynamic systems problem. Recovery isn't a straight line from injured to healed; it's a system with multiple interacting variables — tissue tolerance, neuromuscular control, psychological state, sport-specific demand — and the clinician's job is to keep the athlete moving through that state space toward full function.
Sam: What's the actual clinical workflow? How does a practitioner operationalize this?
Alex: The paper describes a structured assessment sequence. You start by identifying the primary impairments — what's actually limiting this athlete right now, whether that's a range-of-motion deficit, a strength asymmetry, a movement pattern deviation, or a psychological barrier. You select an intervention targeted at the highest-priority impairment, apply it, and immediately reassess the same variable. If reassessment shows improvement, you've confirmed the hypothesis and can progress. If not, you revise.
Sam: It sounds rigorous in principle, but I'd push back on the implementation side. How do you standardize "improvement" across clinicians? The whole model depends on the quality of the hypothesis and the sensitivity of the reassessment.
Alex: That's the paper's most significant limitation, and the authors don't fully resolve it. This is a conceptual framework paper — there's no RCT, no prospective cohort, no head-to-head comparison with standard protocol-driven care. The return-to-sport figures are drawn from existing literature, not from a trial testing SPEAR itself. So the causal claim — that adopting this paradigm would close that gap — is plausible and mechanistically grounded, but it's not yet empirically supported.
Sam: So this is a theoretical architecture waiting for a trial to validate it.
Alex: That's a fair characterization. The value of the paper is in formalizing the framework clearly enough that it could be operationalized and tested. What it doesn't give you is effect size estimates, implementation fidelity metrics, or any data on whether clinicians trained in SPEAR actually produce better outcomes than those following standard protocols.
Sam: What would a rigorous test of this look like?
Alex: You'd want a multi-site RCT with standardized training in the SPEAR approach, and pre-registered outcome measures that go beyond return-to-sport rates — sport-specific performance benchmarks, re-injury rates at one and two years, validated psychological readiness scales, and enough follow-up to capture the full return-to-performance trajectory. The re-injury rate is particularly important because one real risk of aggressive optimal loading is pushing athletes through a window of vulnerability faster than their tissue can consolidate.
Sam: That's a genuine tension. The model is designed to accelerate progress through impairment-driven loading, but if the within-session reassessment misses a subclinical tissue response, you could be setting up a re-injury.
Alex: Which is why the reassessment has to be sensitive enough to catch early warning signals — and that brings us back to your point about standardization. The model's validity depends on clinician skill in a way that protocol-driven care explicitly tries to avoid. That's not necessarily a flaw, but it does mean implementation fidelity becomes a critical variable in any trial. You're essentially trading the reliability of a fixed protocol for the potential accuracy of individualized clinical reasoning — and whether that trade is worth it is an empirical question the field still needs to answer.
Sam: So the paper is arguing we've been prioritizing reliability over accuracy — and that the consistency of fixed protocols comes at the cost of actually getting athletes back to full performance.
Alex: That's a precise summary. The SPEAR framework is a bet that a more demanding, individualized model — one that requires better clinical reasoning and real-time adaptation — will outperform a standardized timeline. Mechanistically coherent, clinically intuitive, but the trial evidence needed to know whether it actually moves the needle doesn't exist yet. That's where the field needs to go next.
Sam: A framework worth taking seriously, but one that needs the empirical work to back it up.
Alex: Exactly where it stands. Thanks for listening to ResearchPod.